Edition:
United Kingdom

People: China Grand Pharmaceutical and Healthcare Holdings Ltd (0512.HK)

0512.HK on Hong Kong Stock

4.35HKD
23 Jul 2019
Change (% chg)

HK$0.03 (+0.69%)
Prev Close
HK$4.32
Open
HK$4.31
Day's High
HK$4.35
Day's Low
HK$4.27
Volume
632,000
Avg. Vol
1,467,975
52-wk High
HK$5.73
52-wk Low
HK$3.26

Zhang, Bangguo 

Mr. Zhang Bangguo is the Director of Zhejiang Xianle of China Grand Pharmaceutical and Healthcare Holdings Limited. He used to work for Grand Pharm (China) as senior management and has over 20 years of experience in pharmaceutical industry and sales and marketing. Mr. Zhang is responsible for overseeing the entire operation and management of Zhejiang Xianle. Mr. Zhang holds a MBA degree at Huazhong University of Science & Technology and holds a practicing pharmacist license in the PRC.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Chengwei Liu

50,000

Yan Shao

1,516,000

Bo Hu

50,000

Zhanqi Niu

--

Yonghua Feng

--

Xiaofeng Shi

--
As Of  31 Dec 2014